Seth Berger, Translational Genomics Director for Rare Disease at Ambry Genetics, shared on LinkedIn:
“To everyone traveling to ASHG 2026, safe travels and hope to see you in Montreal.
Excited to see all the advances particularly in the Long Read Sequencing space. If you’d like to find a time to chat while there, send me a message.
About ASHG 2026
ASHG 2026 is the Annual Meeting of the American Society of Human Genetics, one of the world’s largest and most prestigious conferences in genetics and genomics. Scheduled for October 20-24, 2026, at the Palais des congrès de Montréal in Montreal, Canada.
Gathering over 7,500 attendees from 75 countries, the conference features more than 100 scientific sessions and 240 exhibitors.
The program includes pre-meeting workshops alongside major highlights such as the Presidential Symposium, ‘Communicating Science in an Uncertain World: Evidence, Storytelling, and Public Trust,’ and the Distinguished Speakers Symposium, which focuses on building globally representative datasets and translating genomic discoveries into health outcomes.
The event also offers career development, networking opportunities, and virtual access through GenomeCast passes for remote participants.”
You can also read: Up-Front NGS in Advanced NSCLC: Real-World Data Link Earlier Molecular Testing to Longer Survival
